Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, December 9 at 2:00 PM ET

Register Free →

This Award Notice opportunity from Department Of Defense was posted on October 31, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

DEXMEDTOMIDINE HYDROCHLORIDE INJECTION, V

Awarded
SPE2DP-26-T-5271Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

Solicitation SPE2DP-26-T-5271, issued by the DLA Troop Support Medical Supply Chain Pharm FSA, is a request for quotations for Dexmedetomidine Hydrochloride Injection for veterinary use. The requirement is for four 10ML multi-dose vials of sterile injectable solution (Dexdomitor 0.5mg/ml), used as a sedative and analgesic for dogs and cats. This FDA-regulated drug must be stored at a controlled room temperature between 15 and 30 degrees Celsius and must not be frozen. The item has a non-extendable shelf life of 24 months. Delivery is required FOB Destination to the 0240 QM Support Company at Smith Barracks in Baumholder, Germany, with an original required delivery date of September 29, 2026, and a delivery window of 20 days after order. Packaging must be commercial and consist of suitable sealed unit containers to prevent breakage, with marking strictly adhering to Medical Marking Standard No. 1, which supersedes MIL-STD-129. The contract incorporates various FAR and DFARS clauses, including requirements for combating trafficking in persons, hazardous material identification, and the safeguarding of covered defense information. Invoicing and payment must be processed electronically through the Wide Area WorkFlow system.

General Info

DLA request for four Dexmedetomidine vials for veterinary use delivered to Baumholder, Germany.

Contract Value

$367.16

NAICS

N/A

Place of Performance

DEU

Set-Aside

NONE

Award Issued Date

Documents

2
PDF, High priority: read this first19 pages · rfq
High
PDF, High priority: read this firstaward
High

Read all 2 documents

Every page of every file, in your free workspace.

Read the documents

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

View Full Breakdown

Ask CLEATUS

I've read this contract. Ask me anything.

Timeline

1 update
PhaseAwarded
Posted

Solicitation

Deadline changed

Response deadline changed from Oct 5, 2026 to Oct 8, 2026.

Awarded

Contract was awarded

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → Defense Logistics Agency
Contacts1 person available
OfficeUSA

Full Description

Show more
DLA award SPE2DP27P0199 posted on DIBBS. Awardee: COVETRUS NORTH AMERICA, LLC (CAGE 4PG41) Total Contract Price: $367.16 Award Date: 10-31-2026 Solicitation: SPE2DP-26-T-5271 Line items: - DEXMEDTOMIDINE HYDROCHLORIDE INJECTION, V (NSN/Part 6509015697067, PR 7018517994)

More opportunities from Department Of Defense → Defense Logistics Agency

Same awarding agency

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS